Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Common Equity: 2020-2024

Historic Common Equity for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $20.1 million.

  • Journey Medical's Common Equity rose 137.03% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year increase of 137.03%. This contributed to the annual value of $20.1 million for FY2024, which is 1.38% down from last year.
  • According to the latest figures from FY2024, Journey Medical's Common Equity is $20.1 million, which was down 1.38% from $20.4 million recorded in FY2023.
  • Journey Medical's Common Equity's 5-year high stood at $42.0 million during FY2021, with a 5-year trough of $10.3 million in FY2020.
  • In the last 3 years, Journey Medical's Common Equity had a median value of $20.1 million in 2024 and averaged $19.1 million.
  • Per our database at Business Quant, Journey Medical's Common Equity soared by 308.50% in 2021 and then crashed by 59.61% in 2022.
  • Journey Medical's Common Equity (Yearly) stood at $10.3 million in 2020, then spiked by 308.50% to $42.0 million in 2021, then crashed by 59.61% to $17.0 million in 2022, then rose by 19.83% to $20.4 million in 2023, then dropped by 1.38% to $20.1 million in 2024.